ResearchMoz

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-01-23
No. Of Pages » 98
 
 
   
 This report covers major aspects of the U.S.  implantable  medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental,  intraocular  lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018. 
   
 The orthopedic  implants  market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated...
Table of Content:

Chapter1Preface
1.1ResearchScopeAndDescription
1.2Research Methodology

Chapter2ExecutiveSummary

Chapter3U.S.ImplantableMedicalDevicesMarketAnalysis
3.1Introduction
3.1.1MarketEnvironment
3.1.2PolicyIssues
3.1.3U.S.KeyIndicatorsForImplantableMedicalDevices
3.2MarketDrivers
3.2.1 HighIncidenceOfChronicDegenerativeDiseases
3.2.2IncreaseInAgingPopulation
3.2.3RiseInPurchasingParityAndIncreaseInHealthcareExpenditure
3.3MarketRestraints
3.3.1HighPriceOfImplantableDevices
3.4MarketOpportunities
3.4.1TechnicalInnovation
3.5Porter’sFiveForcesAnalysis
3.5.1BargainingPowerOfBuyers
3.5.2BargainingPowerOfSuppliers
3.5.3ThreatOfSubstitutes
3.5.4ThreatOfNewEntrants
3.5.5CompetitiveRivalry
3.6MarketAttractivenessAnalysis
3.6.1U.S.ImplantableMedicalDevicesMarket,MarketAttractivenessAnalysis,2011

Chapter4U.S.ImplantableMedicalDevicesMarket,ProductSegmentation
4.1Overview
4.1.1CurrentScenario
4.1.1.1U.S.ImplantableMedicalDevicesMarket–TrendsandForecast,2010-2018(USDMillion)
4.1.2U.S.OrthopedicImplantsMarket
4.1.2.1Currentscenario
4.1.2.2ReconstructiveJointReplacements
4.1.2.2.1U.S.ReconstructiveJointReplacementMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.3SpinalImplants
4.1.2.3.1U.S.SpinalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.4Orthobiologics
4.1.2.5Traumafixationimplants
4.1.2.6OtherImplants
4.1.3CardiovascularImplants
4.1.3.1U.S.CardiovascularImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.3.2PacingDevices
4.1.3.3StructuralCardiacDevices
4.1.3.4CardiacStents
4.1.4DentalImplants
4.1.4.1U.S.DentalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.5IntraocularLens(Iols)
4.1.5.1U.S.IntraocularLensMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.6BreastImplants
4.1.6.1U.S.BreastImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.7OtherImplants
4.1.7.1U.S.OtherImplantableMedicalDevicesMarket,TrendsandForecast,2010–2018(USDMillion)

Chapter5U.S.ImplantableMedicalDevicesMarket,ByProcedures
5.1Overview
5.2U.S.OrthopedicImplantProcedures–TrendsAndForecast,2010–2018
5.2.1U.S.OrthopedicImplantProceduresMarket,2010–2018
5.2.2KneeReplacements
5.2.3SpinalFusionAndFixation
5.2.3.1U.S.SpinalFusionandFixationProceduresMarket,TrendandForecast,2010-2018
5.2.4FractureRepairProcedures
5.3U.S.CardiovascularImplantProcedures–TrendsAndForecast,2010–2018
5.3.1U.S.CardiovascularImplantProceduresMarket,2010–2018
5.3.2StentingProcedures
5.3.2.1U.S.StentingProceduresMarket,TrendandForecast,2010–2018
5.3.3DefibrillatorImplantation
5.3.3.1U.S.DefibrillatorImplantationProceduresMarket,TrendAndForecast,2010–2018
5.4U.S.OtherImplantProcedures–TrendsAndForecast,2010–2018
5.4.1IntraocularLensImplantProcedures
5.4.2BreastAugmentation
5.4.2.1U.S.BreastAugmentationProceduresMarket,TrendandForecast,2010–2018

Chapter6CompetitiveLandscapeAndRecommendations
6.1MarketShareAnalysisOfKeyPlayers,2011
6.1MarketStrategyForSuccess
6.2BarriersToBeConsidered

Chapter7CompanyProfiles
7.1AbbottLaboratories
7.1.1CompanyOverview
7.1.2FinancialOverview
7.1.3SwotAnalysis
7.1.4ProductPortfolio
7.1.1StrategicDevelopments
7.1.1.1BusinessDiversification
7.1.1.2R&DInitiatives
7.1.1.3InvestingInEmergingMarkets
7.1.2RecentDevelopments
7.2AlconLaboratories
7.2.1CompanyOverview
7.2.2FinancialOverview
7.2.3SwotAnalysis
7.2.4ProductPortfolio
7.2.5RecentDevelopments
7.3BiometIncorporated
7.3.1CompanyOverview
7.3.2FinancialOverview
7.3.3SwotAnalysis
7.3.4StrategicDevelopments
7.3.4.1Mergers,AcquisitionsAndTakeovers
7.3.5RecentDevelopments
7.4BauschAndLombIncorporated
7.4.1CompanyOverview
7.4.2SwotAnalysis
7.4.3StrategicDevelopments
7.4.3.1Mergers,AcquisitionsAndTakeovers
7.4.3.2NewProductLaunches
7.4.4RecentDevelopments
7.5BostonScientificCorporation
7.5.1CompanyOverview
7.5.2FinancialOverview
7.5.3SwotAnalysis
7.5.4StrategicDevelopments
7.5.4.1Mergers,AcquisitionsAndTakeovers
7.5.4.2NewProductApprovals
7.5.5RecentDevelopments
7.6JohnsonAndJohnson
7.6.1CompanyOverview
7.6.2FinancialOverview
7.6.3SwotAnalysis
7.6.4StrategicDevelopments
7.6.4.1Mergers,AcquisitionsAndTakeovers
7.6.4.2NewProductApprovalsAndLaunch
7.6.5RecentDevelopments
7.7MedtronicIncorporated
7.7.1CompanyOverview
7.7.2FinancialOverview
7.7.3SwotAnalysis
7.7.4ProductPortfolio
7.7.5StrategicDevelopments
7.7.6RecentDevelopments
7.8St.JudeMedicalIncorporated
7.8.1CompanyOverview
7.8.2FinancialOverview
7.8.3SwotAnalysis
7.8.4StrategicDevelopments
7.8.4.1SignificantR&DInvestmentsForNewProductDevelopment
7.8.4.2MergersAndAcquisitions
7.8.5RecentDevelopments
7.9SmithAndNephewPlc
7.9.1CompanyOverview
7.9.2FinancialOverview
7.9.3SwotAnalysis
7.9.4StrategicDevelopments
7.9.4.1Mergers,AcquisitionsAndTakeovers
7.9.5RecentDevelopments
7.10StrykerCorporation
7.10.1CompanyOverview
7.10.2FinancialOverview
7.10.3SwotAnalysis
7.10.4StrategicDevelopments
7.10.4.1Mergers,AcquisitionsAndTakeovers
7.10.5RecentDevelopments
7.11SynthesIncorporated
7.11.1CompanyOverview
7.11.2FinancialOverview
7.11.3SwotAnalysis
7.11.4StrategicDevelopments
7.11.5RecentDevelopments
7.12ZimmerHoldingsIncorporated
7.12.1CompanyOverview
7.12.2FinancialOverview
7.12.3SwotAnalysis
7.12.4StrategicDevelopments
7.12.5RecentDevelopments

List of Tables


Table 1 The U.S. Implantable Medical Devices Market: Snapshot

List of Figures


fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter’s Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. OrthopedicImplants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

Upcoming Reports:

Greece: herbicides and plant-growth regulators market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the herbicides and plant-growth regulators market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the herbicides and plant-growth regulators market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same...
Greece: fruit jams market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fruit jams market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fruit jams market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Captive Power Generation Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2014 - 2020
By - Transparency Market Research
Burgeoning power demand coupled with presence of cross-subsidy charge in the per unit power generation cost are the key factors driving growth in the global captive power generation market. Growing power demand worldwide along with the increasing urbanization, industrialization and a growing population is anticipated to boost growth in the global captive power generation market. Captive power generation refers to power generation plant set up by any individual or industry for its own consumption; it may include a power generation plant set up by association of persons or cooperative...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...